Herzliche Einladung zu unserem 4. Ostseesymposium der Viszeralonkologie!
ostsee-symposium.org
2
86
Great work by @LichunMa and @XinWang77 dissecting intratumoral heterogeneity of primary liver cancer nature.com/articles/s41467-0…
#ascogi22 Great presentation by Augusto Villanueva @augustoNYC and many others on primary liver cancer. Practice Changing results from TOPAZ-1 in #BiliaryTractCancer and HIMALAYA #HCC later today.
5
Outstanding work by Dr. Czauderna highlighting the importance of early epigenetic alterations in HCC. Thanks to everybody for the great contribution @jaboeje @ColmJJORourke insight.jci.org/articles/vie…
Jens Marquardt retweeted
#News: The @EU_Commission has granted approval for a new treatment for adults with locally advanced or metastatic #cholangiocarcinoma with FGFR2 fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
The co‐mutational spectrum determines the therapeutic response in murine FGFR2 fusion ‐ driven cholangiocarcinoma aasldpubs.onlinelibrary.wile…
p53-independent induction of p21 fails to control regeneration and hepatocarcinogenesis in a murine liver injury model cmghjournal.org/article/S235…
1
I will be a participant at Digital #LiverCancerSummit 2021. Join me there to discuss the latest knowledge on #livercancer. Together we are stronger against liver cancer. Find out more about the event: https://nitter.cf/t.co/8glWYrzbDj @EASLnews


